In this Section |
146762 Examinations of Hospitals Return on Assets pre and Post the Balanced Budget Act (BBA)Monday, November 5, 2007
The Balanced Budget Act of 1997 (BBA) reduced the payment for service providers and reduced the subsidy paid by the government for hospitals. Since the passage of such cost containment measures, debates regarding their impact on hospitals. We examined the relationship between the BBA and hospital profitability by using return on assets to measure profitability, by running an ordinary least squares regression for 1996 as pre-BBA and 1999 as post-BBA. We controlled for variables that were not included in previous literature, such as critical access hospital, medical education. Furthermore we incorporated several economic, financial, in the model. We found that overall hospital profitability declined as a result of the introduction of the BBA; however, small rural hospitals that converted to critical access status enjoyed improvement in financial status over the period of our study. Hospitals that converted to for-profit status did not improve in financial status, and showed a lower earning after the conversation. Our results show that the BBA had a negative effect on hospitals because of cuts in its reimbursement policy, except for critical access hospitals, which show improvement because of their exemption from the prospective payment system. Our study differs from others by using national comprehensive data for years that focus exclusively on the Balanced Budget Act period. We deliberately excluded any period that might be affected by the Balanced Budget Refinement Act (BBRA) of 1999, to clarify the severity of the BBA cut on hospital financial performance.
Learning Objectives: Keywords: Balanced Budget Act, Hospitals
Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: na Any relevant financial relationships? No I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
See more of: Hospital Cost and Environmental Impact on Healthcare
See more of: Health Administration |